The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice

Donna R Parker, Charles B Eaton, David K Ahern, Mary B Roberts, Caitlin Rafferty, Roberta E Goldman, F Dennis McCool, Joseph Wroblewski, Donna R Parker, Charles B Eaton, David K Ahern, Mary B Roberts, Caitlin Rafferty, Roberta E Goldman, F Dennis McCool, Joseph Wroblewski

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease associated with significant clinical burden and is estimated to affect 15 million individuals in the US. Although a large number of individuals are diagnosed with COPD, many individuals still remain undiagnosed due to the slow progression of the disorder and lack of recognition of early symptoms. Not only is there under-diagnosis but there is also evidence of sub-optimal evidence-based treatment of those who have COPD. Despite the development of international COPD guidelines, many primary care physicians who care for the majority of patients with COPD are not translating this evidence into effective clinical practice.

Method/design: This paper describes the design and rationale for a randomized, cluster design trial (RCT) aimed at translating the COPD evidence-based guidelines into clinical care in primary care practices. During Phase 1, a needs assessment evaluated barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from focus groups, three tools were developed. These include a computerized patient activation tool (an interactive iPad with wireless data transfer to the spirometer); a web-based COPD guideline tool to be used by primary care providers as a decision support tool; and a COPD patient education toolkit to be used by the practice team. During phase II, an RCT will be performed with one year of intervention within 30 primary care practices. The effectiveness of the materials developed in Phase I are being tested in Phase II regarding physician performance of COPD guideline implementation and the improvement in the clinically relevant outcomes (appropriate diagnosis and management of COPD) compared to usual care. We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker.

Discussion: Using a multi-modal intervention of patient activation and a technology-supported health care provider team, we are testing the effectiveness of this intervention in activating patients and improving physician performance around COPD guideline implementation.

Trial registration: ClinicalTrials.gov, NCT01237561.

Figures

Figure 1
Figure 1
Overview of the RCT study design in phase II of translating the COPD guidelines into primary care practice.

References

    1. Center for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults – United States, 2011. Morb Mortal Wkly Rep. 2012;61(46):938–943.
    1. American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD. 2013. Accessed at .
    1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet. 2004;364:613–620. doi: 10.1016/S0140-6736(04)16855-4.
    1. De Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert B, Janson C, Gislason R, Vermeire P, Svanes C, Anto JM, Burney P. European Community Respiratory Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004;59(2):120–125. doi: 10.1136/thorax.2003.011163.
    1. Calverley PM. COPD: early detection and intervention. Chest. 2000;117(5 suppl 2):365S–71S.
    1. The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease. 2013. Accessed at .
    1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.l NHLBI/WHO Global Initiative to Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276. doi: 10.1164/ajrccm.163.5.2101039.
    1. Van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D. Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology. 2005;10:323–333. doi: 10.1111/j.1440-1843.2005.00720.x.
    1. Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, Donner CF. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice Data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129:844–852. doi: 10.1378/chest.129.4.844.
    1. Wise RA, Tashkin DP. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient. Am J Med. 2007;120(8 suppl 1):S14–22.
    1. 2013 Update Workshop Report, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated 2013. 2013. Accessed at 2013. .
    1. Yawn BP, Enright PL, Lemanske RF, Israel E, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians’ offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162–1168. doi: 10.1378/chest.06-2722.
    1. Kaminsky DA, Marcy TW, Bachand M, Irvin CG. Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care. 2005;50(12):1639–1648.
    1. Townsend MC. Conflicting definitions of airway obstruction: drawing the line between normal and abnormal. Chest. 2007;131(2):335–336. doi: 10.1378/chest.06-2736.
    1. Walker P, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006;28(5):945–952. doi: 10.1183/09031936.06.00019306.
    1. Improving chronic illness care. 2013. Accessed at .
    1. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, Coleman EA. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care. 2001;24(4):695–700. doi: 10.2337/diacare.24.4.695.
    1. Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care. Effects on patient outcomes. . Ann Intern Med. 1985;102(4):520–8. doi: 10.7326/0003-4819-102-4-520.
    1. Geenfield S, Kaplan SH, Ware JE, Yano EM, Frank HJ. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448–457. doi: 10.1007/BF02595921.
    1. Lorig KR, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, Gonzalez VM, Laurent DD, Holman HR. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14. doi: 10.1097/00005650-199901000-00003.
    1. Hibbard JH, Stockard J, Mahoney ER, Tussler M. Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4):1005–1026. doi: 10.1111/j.1475-6773.2004.00269.x.
    1. Parker DR, Evangelou E, Eaton CB. Intraclass correlation coefficients for cluster randomized trials in primary care: The Cholesterol Education and Research Trial (CEART) Contemporary Clinical Trials. Formerly Control Clinic Trials. 2005;26(2):260–267.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel